zeinab kordestani

Ms. zeinab kordestani


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
NENasser Ebrahimpour
Nasser Ebrahimpour
MMMehrnaz Mehrabani
Mehrnaz Mehrabani
MIMaryam Iranpour
Maryam Iranpour
ZKzeinab kordestani
zeinab kordestani
MMMitra Mehrabani
Mitra Mehrabani
MMMehrzad Mehrbani
Mehrzad Mehrbani

20 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSMojgan Sanjari
Mojgan Sanjari
ZKzeinab kordestani
zeinab kordestani
MSMoeinadin Safavi
Moeinadin Safavi
MMMahdieh Mashrouteh
Mahdieh Mashrouteh
MFMaryam FekriSoofiAbadi
Maryam FekriSoofiAbadi
ATAmirfarhad Ghaseminejad Tafreshi
Amirfarhad Ghaseminejad Tafreshi
A direct association has been shown between Cyclin D1 and C-myc gene expressions and the proliferation of human thyroid tumor cells. Our previous study showed that increased β catenin led to a reduction in disease-free probability in patients with papillary thyroid cancer. This study was designed to investigate Cyclin D1 and C-myc genes as targets for β catenin function in PTC and to determine the association between genes expression and staging, recurrence, metastasis, and disease-free survival of PTC. This study was conducted via a thorough investigation of available data from medical records as well as paraffin blocks of 77 out of 400 patients over a 10-year period. Cyclin D1 and C-myc gene expression levels were measured using real-time polymerase chain reaction (RT-PCR) and the Kaplan-Meier method was used to evaluate disease-free survival. Higher levels of Cyclin D1 and C-myc gene expressions were observed in patients with recurrence by 8.5 (P = 0.004) and 19.5 (p = 0.0001) folds, respectively. A significant positive correlation was found between Cyclin D1 expression and the cumulative dose of radioactive iodine received by patients (r = −0.2, p value = 0.03). The ten-year survival rate in the patients included in this study was 98.25% while disease-free survival was 48.1%. Higher Cyclin D1 and C-myc gene expression levels were observed in patients with recurrence/distant metastasis. Inversely, lower expression of Cyclin D1 and C-myc genes were associated with better survival of patients (SD, 0.142-0.052) (Mantel-Cox test, P = 0.002). The enhancement of Cyclin D1 and C-myc gene expression may be a potential mechanism for recurrence and aggressiveness of PTC.

4 July 2023 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
LALadan Amirkhosravi
Ladan Amirkhosravi
ZKzeinab kordestani
zeinab kordestani
RNRohollah Nikooei
Rohollah Nikooei
ZSZohreh Safi
Zohreh Safi
MYMahboobeh Yeganeh-Hajahmadi
Mahboobeh Yeganeh-Hajahmadi
MMMaryamossadat Mirtajaddini-Goki
Maryamossadat Mirtajaddini-Goki

14 October 2022 in Annales Pharmaceutiques Françaises
Verified
Journal Article
Closed access
MTM. Esmaeili Tarzi
M. Esmaeili Tarzi
ZKzeinab kordestani
zeinab kordestani
MMMehrnaz Mehrabani
Mehrnaz Mehrabani
RYR. Yahyapour
R. Yahyapour
MRM. Raeiszadeh
M. Raeiszadeh
FSFariba Sharififar
Fariba Sharififar

1 May 2020
Verified
Closed access
PDF file
SPSaeedeh Parvaresh
Saeedeh Parvaresh
ZKzeinab kordestani
zeinab kordestani
NYNajmeh Yazdankhah
Najmeh Yazdankhah
KDKouros Divsalar
Kouros Divsalar